Strategy Inc. vs Sana Biotechnology Inc — how do they compare? Strategy Inc. trades at $101.75 (market cap $35.47B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Strategy Inc. is far larger — about 40.6× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| MSTR | SANA | |
|---|---|---|
Market Cap | $35.47B | $873.84M |
Sector | Technology | Health |
52-Week High | $426.40 | $5.92 |
52-Week Low | $82.31 | $2.68 |
Enterprise Value | $50.50B | $848.03M |
Trailing returns across standard periods
Latest headlines on both assets
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →